(S (NP-SBJ Nuclear/JJ NF-ATp/NN) (VP is/VBZ (NP-PRD (NP a/DT hallmark/NN) (PP of/IN (NP (NP unstimulated/JJ B/NN cells/NNS) (PP from/IN (NP B-CLL/NN patients/NNS)))))) ./.)
(S (NP-SBJ-41 (NP B/NN lymphocytes/NNS) (PP from/IN (NP (NP the/DT peripheral/JJ blood/NN) (PP of/IN (NP (NP patients/NNS) (PP with/IN (NP (NP chronic/JJ lymphocytic/JJ leukaemia/NN) (PRN -LRB-/-LRB- (NP CLL/NN) -RRB-/-RRB-)))))))) (VP were/VBD (VP analysed/VBN (NP *-41/-NONE-) (PP for/IN (NP (NP the/DT (NP-COOD (NP nuclear/JJ presence/NN) and/CC (NP DNA/NN binding/NN))) (PP of/IN (NP (NP a/DT panel/NN) (PP of/IN (NP (NP transcription/NN factors/NNS) (SBAR (WHNP-42 which/WDT) (S (NP-SBJ-43 *T*-42/-NONE-) (VP are/VBP (VP involved/VBN (NP *-43/-NONE-) (PP in/IN (NP (NP the/DT gene/NN control/NN) (PP of/IN (NP lymphoid/JJ cells/NNS)))))))))))))))) ./.)
(S (NP-SBJ-44 (NP The/DT following/JJ transcription/NN factors/NNS) (NP *ICH*-107/-NONE-)) (VP were/VBD (VP studied/VBN (NP *-44/-NONE-) :/: (NP-COOD-107 (NP the/DT Octamer/NN factors/NNS (NP-COOD (NP Oct-1/NN) and/CC (NP Oct-2/NN))) ,/, (NP (NP members/NNS) (PP of/IN (NP the/DT AP-1/NN factor/NN family/NN))) ,/, (NP (NP NF-AT/NN factors/NNS) ,/, (NP (PP in/IN (NP particular/JJ)) NF-ATp/NN)) ,/, and/CC (NP (NP members/NNS) (PP of/IN (NP the/DT Rel\/NF-kB/NN family/NN)))))) ./.)
(S (NP-SBJ We/PRP) (VP show/VBP (SBAR that/IN (S (NP-SBJ (NP the/DT constitutive/JJ nuclear/JJ translocation/NN) (PP of/IN (NP (NP NF-ATp/NN) ,/, (NP (NP a/DT member/NN) (PP of/IN (NP (NP the/DT growing/VBG family/NN) (PP of/IN (NP NF-AT/NN factors/NNS))))) ,/,))) (VP is/VBZ (NP-PRD (NP a/DT hallmark/NN) (PP of/IN (NP (NP nonstimulated/JJ B/NN cells/NNS) (PP from/IN (NP CLL/NN patients/NNS)))) (SBAR (WHNP-45 that/WDT) (S (NP-SBJ *T*-45/-NONE-) (VP distinguishes/VBZ (NP B-CLL/NN cells/NNS) (PP from/IN (NP '/`` normal/JJ '/'' B/NN lymphocytes/NNS)))))))))) ./.)
(S (NP-SBJ-46 Constitutive/JJ nuclear/JJ appearance/NN) (VP was/VBD (ADVP also/RB) (VP observed/VBN (NP *-46/-NONE-) (PP for/IN (NP NF-kB2\/p52/NN)))) ./.)
(S (NP-SBJ-47 (NP Constitutive/JJ binding/NN) (PP of/IN (NP (NP further/JJ factor/NN proteins/NNS) (PP *ICH*-108/-NONE-))) (PP to/TO (NP DNA/NN)) ,/, (PP-108 such/JJ as/IN (NP-COOD (NP JunD/NN) ,/, (NP c-Fos/NN) and/CC (NP FosB/NN))) ,/,) (VP was/VBD (VP detected/VBN (NP *-47/-NONE-) (PP in/IN (NP several/JJ patients/NNS)) (SBAR whereas/IN (S (NP-SBJ (NP the/DT (NP-COOD (NP localisation/NN) and/CC (NP DNA/NN binding/NN))) (PP of/IN (NP (NP other/JJ factors/NNS) (PP such/JJ as/IN (NP-COOD (NP c-Jun/NN) ,/, (NP RelA\/p65/NN) and/CC (NP c-Rel/NN)))))) (VP was/VBD (ADJP-PRD unaltered/JJ)))))) ./.)
(S (NP-SBJ (NP It/PRP) (SBAR *EXP*-48/-NONE-)) (VP is/VBZ (ADJP-PRD remarkable/JJ) (SBAR-48 that/IN (S (PP in/IN (NP B-CLL/JJ cells/NNS)) (NP-SBJ-49 (NP the/DT (NP-COOD (NP nuclear/JJ appearance/NN) and/CC (NP DNA/NN binding/NN))) (PP of/IN (NP specific/JJ transcription/NN factors/NNS))) (VP is/VBZ (ADVP dramatically/RB) (VP affected/JJ (NP *-49/-NONE-) (SBAR whereas/IN (S (NP-SBJ (NP other/JJ members/NNS) (PP of/IN (NP the/DT same/JJ factor/NN family/NN))) (VP remained/VBD (ADJP-PRD unaltered/JJ) (PP in/IN (NP these/DT leukemic/JJ cells/NNS)))))))))) ./.)
(S (NP-SBJ-51 It/PRP) (VP remains/VBZ (S (NP-SBJ *-51/-NONE-) (VP to/TO (VP be/VB (VP shown/VBN (SBAR (WHNP-52 which/WDT molecular/JJ events/NNS) (S (NP-SBJ *T*-52/-NONE-) (VP lead/VBP (PP to/TO (NP (NP (NP the/DT specific/JJ '/`` pre-activation/NN '/'') ,/, (NP (ADVP i.e./FW) (NP-COOD (NP constitutive/JJ nuclear/JJ translocation/NN) and/CC (NP DNA/NN binding/NN))) ,/,) (PP of/IN (NP (NP these/DT members/NNS) (PP of/IN (NP (NP-COOD (NP NF-AT/NN) ,/, (NP NF-kB/NN) and/CC (NP AP-1/NN)) factor/NN families/NNS)))))))))))))) ./.)
